IP Verse

N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use Thereof

Patent No. EP3632907 (titled "N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use Thereof") was filed by Abbisko Therapeutics on May 22, 2018. The application was issued on Feb 28, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DECIPHERA PHARMACEUTICALSNov 13, 2024MARKS & CLERK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3632907

ABBISKO THERAPEUTICS
Application Number
EP18805288A
Filing Date
May 22, 2018
Status
Granted And Under Opposition
Jan 26, 2024
Publication Date
Feb 28, 2024
External Links
Slate, Register , Google Patents